Discover
BNGO
Bionano Genomics, Inc.
1.17
2 x 0.84
2 x 1.44
bid
ask
+
0.04
3.54%
2 @ 04:00 PM
1.18 +0.01 (0.85%)
| Ytd | -23.53% | |
| 1y | -64.55% |
1.12
day range
1.18
1.06
52 week range
5.50
| Open | 1.16 | Prev Close | 1.13 | Low | 1.12 | High | 1.18 | Mkt Cap | 13.43M |
| Vol | 232.78K | Avg Vol | 150.23K | EPS | -4.46 | P/E | N/A | Forward P/E | -0.41 |
| Beta | 2.38 | Short Ratio | 3.81 | Inst. Own | 12.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.20 | 200-d Avg | 1.43 | 1yr Est | 1.00 |
| Income Statement | |||
| Total Revenue | 6.69M | ||
| Revenues (USD) | 6.69M | ||
| Cost of Revenue | 3.44M | ||
| Gross Profit | 3.25M | ||
| Operating Expenses | 11.15M | ||
| Research and Development Expense | 3.14M | ||
| Selling, General and Administrative Expense | 8.01M | ||
| Operating Income | -7.90M | ||
| Income Tax Expense | 10.00K | ||
| Net Income | -8.30M | ||
| Net Income Common Stock | -8.30M | ||
| Net Income Common Stock (USD) | -8.30M | ||
| Consolidated Income | -8.30M | ||
| Earnings per Basic Share | -0.76 | ||
| Earnings per Basic Share (USD) | -0.76 | ||
| Earnings per Diluted Share | -0.76 | ||
| Earning Before Interest & Taxes (EBIT) | -8.29M | ||
| Earning Before Interest & Taxes (USD) | -8.29M | ||
| Weighted Average Shares | 10.98M | ||
| Weighted Average Shares Diluted | 10.98M | ||
| Balance Sheet | |||
| Cash and Equivalents | 13.69M | ||
| Cash and Equivalents (USD) | 13.69M | ||
| Investments | 10.98M | ||
| Investments Current | 10.98M | ||
| Trade and Non-Trade Receivables | 4.13M | ||
| Current Assets | 38.98M | ||
| Property, Plant & Equipment Net | 20.15M | ||
| Total Assets | 64.80M | ||
| Debt Current | 11.04M | ||
| Total Debt | 17.01M | ||
| Current Liabilities | 21.23M | ||
| Debt Non-Current | 5.97M | ||
| Total Liabilities | 27.34M | ||
| Accumulated Retained Earnings (Deficit) | -727.92M | ||
| Accumulated Other Comprehensive Income | 12.00K | ||
| Shareholders Equity | 37.46M | ||
| Shareholders Equity (USD) | 37.46M | ||
| Assets Non-Current | 25.83M | ||
| Total Debt (USD) | 17.01M | ||
| Deferred Revenue | 1.27M | ||
| Goodwill and Intangible Assets | 3.01M | ||
| Inventory | 5.31M | ||
| Liabilities Non-Current | 6.11M | ||
| Trade and Non-Trade Payables | 5.06M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.48M | ||
| Net Cash Flow from Financing | 657.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 403.00K | ||
| Issuance (Purchase) of Equity Shares | 677.00K | ||
| Issuance (Repayment) of Debt Securities | -20.00K | ||
| Net Cash Flow from Investing | 5.46M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 5.46M | ||
| Net Cash Flow from Operations | -5.72M | ||
| Effect of Exchange Rate Changes on Cash | 5.00K | ||
| Share Based Compensation | 670.00K | ||